First COVID-19 pill passes human trials, looks to FDA approval
Pharma company Merck has revealed the first data from its large trial of a pill for COVID-19. The results show the drug reduces a person’s risk of hospitalization or death from COVID-19 by 50 percent when taken within five days of symptoms appearing. Source of Article